GSK · Pharma and healthcare · one day
GSK (GSK): news on Sunday 8 November 2026
News from the 24 hours to Sunday morning, 8 November 2026.
Tone of the day
What the score means. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Why it scored this way
Coverage centred on GSK settling its global patent dispute with Moderna over COVID-19 and RSV vaccines, which leans positive as it clears legal uncertainty. A routine note on the upcoming dividend added a mildly supportive tone.
What drove it
- Moderna patent settlement
- upcoming dividend
Around this day
| Day | Tone | Headlines |
|---|---|---|
| Mon 2 Nov | +8.0 | 3 |
| Tue 3 Nov | +2.7 | 6 |
| Wed 4 Nov | +5.0 | 14 |
| Thu 5 Nov | +5.0 | 11 |
| Fri 6 Nov | +4.5 | 8 |
| Sat 7 Nov | +4.5 | 17 |
| Sun 8 Nov | +5.7 | 2 |
| Mon 9 Nov | −3.3 | 3 |
| Tue 10 Nov | +6.3 | 13 |
| Wed 11 Nov | +4.5 | 6 |
| Thu 12 Nov | +4.5 | 12 |
| Fri 13 Nov | +4.2 | 14 |
2 stories · 2 headlines · strongest first
Pharma and healthcare on 8 NovemberFTSE 100 that day| Tone | What the article reported, and why it scored that way | |
|---|---|---|
| Moderna and GSK resolve dispute over vaccine patents +5.71 headline today · 11 in all, since 7 November · GSK and Moderna have resolved their worldwide patent dispute over vaccines for COVID-19 and RSV. | ||
| +7.0 | Resolving a global patent dispute removes litigation uncertainty over its vaccines. | |
| GSK upcoming dividend +2.01 headline today · A piece notes four days remain before the dividend. | ||
| +2.0 | Dividend payout approaching; routine shareholder income information. | |
Each article has its own score. The lines are our own summary; follow the source link to read the article itself.
Follow by email
A short, free morning email on how the news treated GSK: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.